Skip to main content

Table 4 Rank of prenatal detection subgroups of CHD

From: Epidemiology, prenatal diagnosis, and neonatal outcomes of congenital heart defects in eastern China: a hospital-based multicenter study

Rank

Subgroup

Prenatal detection

Proportion (%)

1

SV/ Q20.4

87

98.9

2

HLHS/ Q23.4

64

98.5

3

DORV/Q20.1

105

97.2

4

PTA/ Q20.0

64

94.1

5

HRH/ Q22.6

37

92.5

6

TOF/Q21.3

245

91.1

7

COA/Q25.3

58

90.6

8

Pulmonary stenosis/Q25.6

101

89.4

9

AoS/Q23.0

8

88.9

10

Dextrocardia/Q24.0

53

86.9

11

Pulmonaryvalve atresia/Q22.0

23

85.2

12

IAA/Q25.4

112

85.5

13

DTGA/Q20.3

72

80.0

14

TAPVR/Q26.2

5

62.5

15

AVSD/Q21.2

205

55.7

16

VSD/Q21.0

649

46.4

17

PDA/Q25.0

121

4.1

18

ASD/Q21.1

206

3.5

  1. SV Single ventricle, HLHS Hypoplastic left heart syndrome, DORV Double outlet right ventricle, PTA Persistent truncus arteriosus, HRH Hypoplastic right heart, TOF Tetralogy of Fallot, COA Coarctation of the aorta, AoS Aortic valve stenosis, IAA Interrupted aortic arch and others, DTGA d-Transposition of great vessels, TAPVR Total anomalous pulmonary venous return, AVSD Atrioventricular septal defect, VSD Ventricular septal defect, PDA Patent ductus arteriosus, ASD, Atrial septal defect